TDC
MD icon

Thompson Davis & Co’s Pediatrix Medical MD Stock Holding History

Thompson Davis & Co’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,053
Closed -$45K – 907
2017
Q3 		$45K Buy
1,053
+286
+37% +$13.6K 0.08% 253
2017
Q2 		$46K Hold
767
– – 0.07% 240
2017
Q1 		$53K Sell
767
-16
-2% -$1.11K 0.08% 244
2016
Q4 		$52K Sell
783
-19
-2% -$1.24K 0.09% 234
2016
Q3 		$53K Hold
802
– – 0.09% 225
2016
Q2 		$58K Hold
802
– – 0.09% 214
2016
Q1 		$52K Hold
802
– – 0.08% 232
2015
Q4 		$57K Hold
802
– – 0.08% 236
2015
Q3 		$62K Sell
802
-56
-7% -$4.52K 0.09% 220
2015
Q2 		$64K Sell
858
-25
-3% -$1.8K 0.07% 267
2015
Q1 		$64K Buy
883
+51
+6% +$3.55K 0.08% 240
2014
Q4 		$55K Buy
832
+264
+46% +$16.1K 0.06% 267
2014
Q3 		$31K Buy
+568
New +$32.2K 0.04% 372

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Thompson Davis & Co's MD Position: Q4 2017 in Review

Thompson Davis & Co sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 1,053 shares — an estimated $45K sold.

Thompson Davis & Co first reported a position in MD in Q3 2014 and held it in 13 quarters. The position peaked at $64K in Q2 2015. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • Thompson Davis & Co reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 1,053 Pediatrix Medical shares in Q4 2017, an estimated $45K.
  • Thompson Davis & Co first reported a position in Pediatrix Medical in Q3 2014 and held it in 13 quarters.
  • Thompson Davis & Co's Pediatrix Medical position peaked at $64K in Q2 2015.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.